Harte-Hanks (HHS) has a profit margin of -0.67%, below the Consumer Discretionary sector average of 9.32%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
The latest profit margin for HHS is -0.67% as of March 2026. That compares with -23.97% in the prior-year period — up 97.2% year over year. That is below the Consumer Discretionary sector average of 9.32%. Investors often review this figure alongside Harte-Hanks's historical trend and sector peers before judging valuation or financial health.
Over the past year, HHS's profit margin moved from -23.97% to -0.67% — a 97.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Harte-Hanks's valuation or profitability profile.
Against Consumer Discretionary companies, HHS currently prints -0.67% for profit margin, while the sector average sits near 9.32%. That is roughly 107.2% below the sector mean. Large gaps often invite a closer look at Harte-Hanks's growth, margins, and balance sheet.
Profit Margin shows how effectively Harte-Hanks converts resources into returns. At -0.67%, HHS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -23.97% in the prior-year period — up 97.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting HHS's profit margin (-0.67%), review year-over-year change from -23.97%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.